II
Illumina Inc
🇺🇸XNAS.ILMNUnited StatesHealthcare
$225.68USDup +3.37 (+1.52%)OpenDelayed4:10 PM
Price$225.68+3.37 (+1.52%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4523271090
- CUSIP
- 452327109
Company
- Employees
- 8,600
- Headquarters
- San Diego, United States
- Website
- https://www.illumina.com
- CEO
- Mr. Jacob Thaysen Ph.D.
Market
- Shares outstanding
- 151M
- Market cap
- $34.08B
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- $33.62B
- EPS LTM
- $5.46calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 41.31calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.49B+4.93%up year on year
- Net income
- $825M-34.42%down year on year
- Gross margin
- 66.79%-0.52%down year on year
- Free cash flow
- $939M-8.92%down year on year
Other listings
- XSTU.ILUStuttgart Stock Exchange
- XFRA.ILUFrankfurt Stock Exchange
- XBER.ILUBerlin Stock Exchange
- XMUN.ILUMunich Stock Exchange
- XDUS.ILUDüsseldorf Stock Exchange
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.